Healthcare · Pharmaceutical spending per capita

Pharmaceutical spending per capita in Malaysia in 2026

Per capita spending on pharmaceutical products in Malaysia is 210 $ in 2026, placing the country 76-th out of 197. This level reflects growing domestic demand for medicines, supported by the expansion of pharmacy networks and an increase in private health insurance coverage. A significant portion of spending goes towards drugs for chronic diseases such as diabetes and hypertension, which are widespread among Malaysians. The government subsidizes medicines in public clinics, which helps contain costs for patients.

Data for 2026 · unit: $
Position

Malaysia world ranking

#76 / 197

Country position on the scale from last to first place for this indicator.

MY
#76
#197#1
Trend

Change over time

Change in indicator over the available period.

40
1990
80
2000
140
2010
190
2020
210
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical spending per capita in Malaysia — how much?
Based on 2026 data — 210 $. This is rank #76 out of 197 countries.
What is Malaysia's rank by Pharmaceutical spending per capita?
Malaysia ranks #76 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in Malaysia?
Over the available period the indicator changed from 40 to 210 $.